Grand Challenges: Blueprint Empowers Drug Development for Nervous System Disorders 

Thursday, August 18, 2011
Image
NIH Default Logo

The Blueprint Neurotherapeutics Network helps investigators develop new drugs for nervous system disorders and prepare for clinical trials. The Network recently made awards to seven teams across the U.S. to develop new therapies for vision loss, neurodegenerative diseases, and depression, among others.

View the full article.